Phibro Animal Health Corporation
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2022 | 2023 | 2024 | 2025 | 2026 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 942.26M | 977.89M | 1.02B | 1.30B | 1.52B | 17.1% | |
| Cost of Revenue | (656.86M) | (679.65M) | (704.59M) | (896.27M) | (1.01B) | 12.2% | |
Gross Profit | 285.40M | 298.24M | 313.09M | 399.94M | 511.71M | 27.9% | |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | |
| Selling, General & Administrative | (206.41M) | (226.39M) | (259.78M) | (289.48M) | (312.50M) | 8.0% | |
| General & Administrative | — | — | — | — | (312.50M) | — | |
| Depreciation & Amortization | (32.70M) | (34.01M) | (36.18M) | (45.60M) | (51.51M) | 13.0% | |
Operating Income (EBIT) | 78.99M | 71.85M | 53.31M | 110.47M | 198.44M | 79.6% | |
| Non-Operating Items | |||||||
| Interest Income | 816.00K | 3.35M | 4.47M | 2.62M | 1.46M | -44.4% | |
| Interest Expense | (12.10M) | (17.95M) | (21.97M) | (33.25M) | (47.60M) | 43.2% | |
| Other Income/Expenses (Net) | -6.66M | -17.78M | -42.40M | -42.47M | -61.09M | 43.8% | |
Income Before Tax | 72.33M | 54.07M | 10.92M | 67.99M | 137.35M | 102.0% | |
| Income Tax Expense | (23.15M) | (21.46M) | (8.50M) | (19.73M) | (37.63M) | 90.7% | |
Net Income | 49.17M | 32.61M | 2.42M | 48.26M | 99.72M | 106.6% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $1 | $1 | $0 | $1 | $2 | 106.7% | |
| Weighted Avg Shares Outstanding | 40.50M | 40.50M | 40.50M | 40.50M | 40.60M | 0.2% | |
| Weighted Avg Shares Outstanding (Diluted) | 40.50M | 40.50M | 40.52M | 40.70M | 41.00M | 0.7% | |
EBITDA | 117.13M | 106.03M | 69.06M | 146.85M | 236.46M | 61.0% |
Explore PAHC
PAHC in the Healthcare
Small Cap